Radscopal Radiotherapy Plus Immunotherapy for Chemotherapy-Ineligible Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer: A Single-Center, Open-Label, Phase II Study
PHASE2
The RADIANCE trial plans to enroll patients with chemotherapy-ineligible de...
Phase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy With or Without Radiotherapy for Advanced Triple-negative Breast Cancer.
PHASE2
Phase II clinical trial of PD-L1 in combination with vinorelbine + cyclopho...
Status
Recruiting
Location
Cancer Hospital, Chinese Academy of Medical Sciences
A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab
PHASE1
This phase I trial studies the safety and side effects of a new positron em...